Fabry Disease Global Clinical Trials Review, H1, 2013

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Fabry Disease Global Clinical Trials Review, H1, 2013
Published on February 2013

Report Summary


Summary

GlobalData's clinical trial report, ' Fabry Disease Global Clinical Trials Review, H1, 2013" provides data on the Fabry Disease clinical
trial scenario. This report provides elemental information and data relating to the clinical trials on Fabry Disease. It includes an
overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a
preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Fabry Disease. This report is built using data and information sourced
from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Content

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Fabry Disease 7
Report Guidance 7
Clinical Trials by Region 8

Fabry Disease Global Clinical Trials Review, H1, 2013 (From Slideshare) Page 1/7


Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Fabry Disease 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Fabry Disease Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Genzyme Corporation 32
Clinical Trial Overview of Genzyme Corporation 32
Amicus Therapeutics, Inc. 34
Clinical Trial Overview of Amicus Therapeutics, Inc. 34
Shire Plc 35
Clinical Trial Overview of Shire Plc 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Green Cross Corporation 38
Clinical Trial Overview of Green Cross Corporation 38
Shire Human Genetic Therapies, Inc. 39
Clinical Trial Overview of Shire Human Genetic Therapies, Inc. 39
Protalix Ltd. 40
Clinical Trial Overview of Protalix Ltd. 40
Genzyme BV 41
Clinical Trial Overview of Genzyme BV 41
O & O Alpan, LLC 42
Clinical Trial Overview of O & O Alpan, LLC 42
GlaxoSmithKline Inc. 43
Clinical Trial Overview of GlaxoSmithKline Inc. 43
ISU ABXIS Co.,Ltd. 44
Clinical Trial Overview of ISU ABXIS Co.,Ltd. 44
GlaxoSmithKline AG 45
Clinical Trial Overview of GlaxoSmithKline AG 45
Abbott Laboratories 46



Clinical Trial Overview of Abbott Laboratories 46
Clinical Trial Overview of Top Universities / Institutes / Hospitals 47
University of Alabama at Birmingham 47
Clinical Trial Overview of University of Alabama at Birmingham 47
Baylor Research Institute 48
Clinical Trial Overview of Baylor Research Institute 48
University of Rostock 49
Clinical Trial Overview of University of Rostock 49
University of Minnesota 50
Clinical Trial Overview of University of Minnesota 50
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 51
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 51
Canadian Fabry Research Consortium 52
Clinical Trial Overview of Canadian Fabry Research Consortium 52
Assistance Publique - Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
Wolfson Medical Center 54
Clinical Trial Overview of Wolfson Medical Center 54
Academic Medical Centre 55
Clinical Trial Overview of Academic Medical Centre 55
Mario Negri Institute for Pharmacological Research 56
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 56
Danish Pain Research Center 57
Clinical Trial Overview of Danish Pain Research Center 57
Ghent University Hospital 58
Clinical Trial Overview of Ghent University Hospital 58
University of Zurich 59
Clinical Trial Overview of University of Zurich 59
Shaare Zedek Medical Center 60
Clinical Trial Overview of Shaare Zedek Medical Center 60
University Hospital, Bordeaux 61
Clinical Trial Overview of University Hospital, Bordeaux 61
Medical University of Vienna 62
Clinical Trial Overview of Medical University of Vienna 62
The Ohio State University 63
Clinical Trial Overview of The Ohio State University 63
Cedars-Sinai Medical Center 64
Clinical Trial Overview of Cedars-Sinai Medical Center 64
Centre Hospitalier Universitaire de Nice 65
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 65
Five Key Clinical Profiles 66
Appendix 82
Abbreviations 82
Definitions 82
Research Methodology 83
Secondary Research 83
About GlobalData 84
Contact Us 84



Disclaimer 84
Source 85

List of Tables
Fabry Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Fabry Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Fabry Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Fabry Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Fabry Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Fabry Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
Fabry Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Fabry Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Fabry Disease Therapeutics Clinical Trials, G7 Countries, 2013* 17
Fabry Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Fabry Disease Therapeutics Clinical Trials, E7 Countries, 2013* 19
Fabry Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Fabry Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Fabry Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Fabry Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Fabry Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Fabry Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Fabry Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Fabry Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Fabry Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 32
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2013* 34
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013* 35
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2013* 38
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Human Genetic Therapies, Inc., 2013* 39
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Protalix Ltd., 2013* 40
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme BV, 2013* 41
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by O & O Alpan, LLC, 2013* 42
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Inc., 2013* 43
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ISU ABXIS Co.,Ltd., 2013* 44
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline AG, 2013* 45
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 46
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 47
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor Research Institute, 2013* 48
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2013* 49
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013* 50
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, 2013* 51



Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Canadian Fabry Research Consortium, 2013* 52
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 53
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Wolfson Medical Center, 2013* 54
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 55
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research,
2013* 56
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Pain Research Center, 2013* 57
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2013* 58
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 59
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2013* 60
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2013* 61
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 62
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013* 63
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2013* 64
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2013* 65

List of Figures
Fabry Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Fabry Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Fabry Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Fabry Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Fabry Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Fabry Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
Fabry Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Fabry Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Fabry Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Fabry Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Fabry Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Fabry Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Fabry Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Fabry Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Fabry Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27
Fabry Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29
Fabry Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
GlobalData Methodology 83


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 500.00 Quantity: _____

Site License--USD 5 000.00 Quantity: _____

Corporate License--USD 7 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Fabry Disease Global Clinical Trials Review, H1, 2013

Recommandé

Recommandé

Contenu connexe

Plus de ReportLinker.com

Plus de ReportLinker.com (20)

Fabry Disease Global Clinical Trials Review, H1, 2013